Barclays lowered the firm’s price target on UnitedHealth (UNH) to $362 from $513 and keeps an Overweight rating on the shares. The firm stress tested 2025 earnings scenarios “to help find a floor” for the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth Stock Crashes as DOJ Launches Criminal Medicare Fraud Probe
- Optimistic Buy Rating for UnitedHealth Amid Challenges and Strategic Growth
- UnitedHealth Stock Tanks: Here’s What Oppenheimer Predicts Next
- Closing Bell Movers: Foot Locker up nearly 70% on Dick’s buyout
- UnitedHealth down another 4% afterhours at $295 after DOJ probe report